EAM Investors, LLC - Q2 2020 holdings

$452 Million is the total value of EAM Investors, LLC's 254 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .

 Value Shares↓ Weighting
OCUL  Ocular Therapeutix Inc$2,883,000
+68.3%
346,0750.0%0.64%
+19.7%
RPAY  Repay Holdings Corp$2,282,000
+71.6%
92,6540.0%0.50%
+22.0%
OVID  Ovid therapeutics Inc$1,361,000
+147.5%
184,7280.0%0.30%
+76.0%
MTBC  MTBC Inc$1,217,000
+50.8%
146,7920.0%0.27%
+7.2%
ATXI  Avenue Therapeutics Inc$1,037,000
+20.4%
96,2550.0%0.23%
-14.2%
PDEX  Pro-Dex Inc$835,000
+10.2%
46,8480.0%0.18%
-21.3%
ACLS  Axcelis Technologies Inc$774,000
+52.1%
27,8030.0%0.17%
+8.2%
GSB  GlobalSCAPE Inc$501,000
+36.9%
51,4010.0%0.11%
-2.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MGP Ingredients, Inc.21Q4 20221.0%
Neogenomics Laboratories, Inc.19Q2 20230.9%
Five9, Inc.19Q3 20201.3%
Cutera, Inc.19Q3 20221.1%
Repligen Corporation19Q4 20200.7%
Kinsale Capital Group, Inc.19Q3 20230.9%
INPHI Corporation18Q2 20200.7%
PAR Technology Corporation18Q3 20230.7%
US CONCRETE INC17Q3 20191.0%
CLEARFIELD INC17Q4 20221.2%

View EAM Investors, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
EAM Investors, LLC Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AUTOBYTEL INCFebruary 10, 2016576,3695.5%

View EAM Investors, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR/A2023-07-12
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13

View EAM Investors, LLC's complete filings history.

Compare quarters

Export EAM Investors, LLC's holdings